Has Candice Baldeo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,521 in general payments to Candice Baldeo, MD across 396 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Candice Baldeo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Candice Baldeo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Candice Baldeo, MD

Hematology & Oncology · Salt Lake City, UTNPI 1518300557

Payments from drug & device makers

$20,521in general payments, 2019–2025

Across 396 payments — averaging $51.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Deciphera Pharmaceuticals Inc.$5K
AstraZeneca$3K
GSK$3K
AbbVie$2K
Amgen$905
Daiichi Sankyo Inc.$684
plus $6K from 44 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Deciphera Pharmaceuticals Inc.	15	$5,099
AstraZeneca(2 entities)	31	$2,822
GSK	1	$2,750
AbbVie	6	$2,372
Amgen	34	$905
Daiichi Sankyo Inc.	10	$684
Genentech USA, Inc.	15	$588
Merck	40	$574
Seagen Inc.	26	$511
Johnson & Johnson	11	$393
Bristol Myers Squibb	11	$390
Pfizer	25	$353
Lilly USA, LLC	16	$349
Sanofi	23	$323
Eisai Inc.	17	$258
Gilead(2 entities)	7	$165
Bayer	6	$157
Incyte Corporation	10	$154
Caris MPI, Inc.	2	$152
Exelixis Inc.	10	$134
Foundation Medicine, Inc.	7	$100
Rigel Pharmaceuticals, Inc.	1	$100
E.r. Squibb & Sons, L.L.C.	7	$98
Tesaro, Inc.	1	$94
Pharmacyclics LLC, An Abbvie Company	6	$86
Dova Pharmaceuticals	6	$82
Ipsen Biopharmaceuticals, Inc	5	$78
Tersera Therapeutics LLC	3	$63
Array Biopharma Inc	4	$62
Novartis	3	$58
Epizyme, Inc.	4	$53
Karyopharm Therapeutics Inc.	4	$53
Genentech, Inc.	1	$50
Sobi, Inc	3	$44
Coherus Oncology, Inc.	3	$41
Clovis Oncology, Inc.	3	$34
Boehringer Ingelheim	2	$33
G1 Therapeutics, Inc.	2	$29
Astellas Pharma US Inc	2	$29
EMD Serono, Inc.	2	$28
Beigene USA, Inc.	2	$25
Tempus AI, Inc	1	$25
Acrotech Biopharma Inc.	1	$18
Regeneron Healthcare Solutions, Inc.	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Morphosys, US Inc.	1	$16
AVEO Pharmaceuticals, Inc.	1	$16
Acceleron Pharma, Inc.	1	$13
Elekta, Inc.	1	$13
Myriad Genetic Laboratories, Inc.	1	$12

How this compares

$20,521 in reported general payments places this provider in the 50th percentile of 77 hematology & oncology providers in Utah.

See all hematology & oncology providers in Utah →

Medicare billing

Part B allowed, 2024

$5,220

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Salt Lake City

Neeraj AgarwalSalt Lake City$32.4M
Douglas SborovSalt Lake City$7.8M
Tsewang TashiSalt Lake City$6.7M
Benjamin MaughanSalt Lake City$5.6M
Daanish HodaSalt Lake City$2.9M
Shiven PatelSalt Lake City$2.9M
Vaia FlorouSalt Lake City$2.3M
Theresa WernerSalt Lake City$1.9M
Heloisa SoaresSalt Lake City$1.7M
Sunil SharmaSalt Lake City$1.5M

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →